Literature DB >> 32925368

Opioids and sleep.

Nicholas J Cutrufello1, Vlad D Ianus2, James A Rowley3.   

Abstract

PURPOSE OF REVIEW: Summarize the effects of opioids on sleep including sleep architecture, sleep disordered breathing (SDB) and restless legs syndrome. RECENT
FINDINGS: Opioids are associated with the development of central sleep apnea (CSA) and ataxic breathing. Recent reports suggest that adaptive servo-ventilation may be an effective treatment for CSA associated with opioids.
SUMMARY: Opioids have multiple effects on sleep, sleep architecture and SDB. Although originally described with methadone use, most commonly used opioids have also been shown to affect sleep. In patients on chronic methadone, sleep architecture changes include decreases in N3 and REM sleep. However, in patients with chronic nonmalignant pain, opioids improve sleep quality and sleep time. Opioids, generally at a morphine equivalent dose more than 100 mg/day, are associated with an increased incidence of CSA and ataxic breathing as well as obstructive sleep apnea. Other risk factors may include concomitant use of other medications such as antidepressants, gabapentinoids and benzodiazepines. Opioid-induced CSA can be potentially treated with adaptive servo-ventilation. Finally, opioids are a potential therapeutic option for restless legs syndrome unresponsive to dopamine agonists and other medications. However, use in patients with restless legs syndrome should proceed with caution, taking into account the risk for dependence and development of SDB.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32925368     DOI: 10.1097/MCP.0000000000000733

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  5 in total

Review 1.  Sleep-mediated regulation of reward circuits: implications in substance use disorders.

Authors:  Rong Guo; Dylan Thomas Vaughan; Ana Lourdes Almeida Rojo; Yanhua H Huang
Journal:  Neuropsychopharmacology       Date:  2022-06-16       Impact factor: 7.853

2.  Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeys.

Authors:  Lais F Berro; C Austin Zamarripa; Joseph T Talley; Kevin B Freeman; James K Rowlett
Journal:  Addict Behav       Date:  2022-07-22       Impact factor: 4.591

3.  Poor Sleep Quality and Other Risk Factors for Unemployment Among Patients on Opioid Agonist Treatment.

Authors:  Margo Huffman; Marianne Cloeren; Orrin D Ware; Jodi J Frey; Aaron D Greenblatt; Amanda Mosby; Marc Oliver; Rachel Imboden; Alicia Bazell; Jean Clement; Montserrat Diaz-Abad
Journal:  Subst Abuse       Date:  2022-05-21

4.  Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.

Authors:  Andrew S Huhn; Patrick H Finan
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.157

Review 5.  Roles of Neuropeptide S in Anesthesia, Analgesia, and Sleep.

Authors:  Tetsuya Kushikata; Kazuyoshi Hirota; Junichi Saito; Daiki Takekawa
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.